Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Metadata
Title
New advances in identifying genetic anomalies in stroke-prone probands
Authors
James F. Meschia, MD
Bradford B. Worrall, MD, MSc
Publication date
01-10-2004
Publisher
Springer Berlin Heidelberg
Published in
Current Neurology and Neuroscience Reports / Issue 5/2004
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-004-0090-9

Other articles of this Issue 5/2004

Current Neurology and Neuroscience Reports 5/2004 Go to the issue

Abstract

Literature alert

OriginalPaper

Estrogen replacement therapy, Alzheimer’s disease, and mild cognitive impairment

OriginalPaper

Medical and surgical management of idiopathic intracranial hypertension in pregnancy

OriginalPaper

Cognitive reserve: Implications for diagnosis and prevention of Alzheimer’s disease

OriginalPaper

Autosomal recessive forms of Charcot-Marie-Tooth disease

OriginalPaper

Retinal, ophthalmic, or ocular migraine